0000899243-21-042095.txt : 20211029 0000899243-21-042095.hdr.sgml : 20211029 20211029193319 ACCESSION NUMBER: 0000899243-21-042095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211028 FILED AS OF DATE: 20211029 DATE AS OF CHANGE: 20211029 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson David Michael CENTRAL INDEX KEY: 0001808098 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40971 FILM NUMBER: 211364851 MAIL ADDRESS: STREET 1: C/O ZENTALIS PHARMACEUTICALS, LLC STREET 2: 530 SEVENTH AVENUE, SUITE 2201 CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aura Biosciences, Inc. CENTRAL INDEX KEY: 0001501796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 320271970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 BOLTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617)500-8864 MAIL ADDRESS: STREET 1: 85 BOLTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-28 0 0001501796 Aura Biosciences, Inc. AURA 0001808098 Johnson David Michael C/O AURA BIOSCIENCES, INC. 85 BOLTON STREET CAMBRIDGE MA 02140 1 0 0 0 Stock Option (Right to Buy) 14.00 2021-10-28 4 A 0 24000 0.00 A 2031-10-27 Common Stock 24000 24000 D The shares underlying this option vest as follows: These shares will vest in full on October 28, 2022. /s/ Julie Feder 2021-10-29